Abstract
Real-world retrospective study of anti-PD-1 antibody in combination with chemotherapy as a neoadjuvant treatment strategy for locally advanced resectable esophageal squamous cell carcinoma
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have